Publikationen, an denen er mitarbeitet Diana E. Ayala García (134)

2021

  1. Cardiovascular disease risk stratification by the Framigham score is markedly improved by ambulatory compared with office blood pressure

    Revista Espanola de Cardiologia, Vol. 74, Núm. 11, pp. 953-961

2020

  1. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial

    European heart journal, Vol. 41, Núm. 48, pp. 4565-4576

2019

  1. Asleep (not night-time) blood pressure as prognostic marker of cardiovascular risk

    European Heart Journal

  2. Diagnosis and management of hypertension: around-the-clock ambulatory blood pressure monitoring is substantially more effective and less costly than daytime office blood pressure measurements

    Chronobiology International, Vol. 36, Núm. 11, pp. 1515-1527

2018

  1. Asleep blood pressure: Significant prognostic marker of vascular risk and therapeutic target for prevention

    European Heart Journal, Vol. 39, Núm. 47, pp. 4159-4171

  2. Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk

    European Journal of Clinical Investigation, Vol. 48, Núm. 5

  3. Risk of incident chronic kidney disease is better reduced by bedtime than upon-awakening ingestion of hypertension medications article

    Hypertension Research, Vol. 41, Núm. 5, pp. 342-353

2017

  1. Bedtime Blood Pressure Chronotherapy Significantly Improves Hypertension Management

    Heart Failure Clinics, Vol. 13, Núm. 4, pp. 759-773

  2. Bedtime Chronotherapy with Conventional Hypertension Medications to Target Increased Asleep Blood Pressure Results in Markedly Better Chronoprevention of Cardiovascular and Other Risks than Customary On-awakening Therapy

    Heart Failure Clinics, Vol. 13, Núm. 4, pp. 775-792

  3. Sleep-time ambulatory BP is an independent prognostic marker of CKD

    Journal of the American Society of Nephrology, Vol. 28, Núm. 9, pp. 2802-2811

  4. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention

    Sleep medicine reviews, Vol. 33, pp. 17-27

2016

  1. Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial

    Diabetologia, Vol. 59, Núm. 2, pp. 255-265

  2. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks

    Hypertension Research, Vol. 39, Núm. 5, pp. 277-292

  3. Elevated asleep BP as predictor of type 2 diabetes and therapeutic target for prevention

    Diabetologia

  4. Erratum to: Bedtime ingestion of hypertension medications reduces the risk of new-onset type 2 diabetes: a randomised controlled trial [Diabetologia, DOI: 10.1007/s00125-015-3749-7]

    Diabetologia

  5. Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention

    Diabetologia, Vol. 59, Núm. 2, pp. 244-254

2014

  1. Abnormalities in chronic kidney disease of ambulatory blood pressure 24 h patterning and normalization by bedtime hypertension chronotherapy

    Nephrology Dialysis Transplantation, Vol. 29, Núm. 6, pp. 1160-1167

  2. Around-the-clock ambulatory blood pressure monitoring is required to properly diagnose resistant hypertension and assess associated vascular risk

    Current Hypertension Reports, Vol. 16, Núm. 7

  3. Chronotherapeutics of conventional blood pressure-lowering medications: Simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders topical collection on antihypertensive agents: Mechanisms of drug action

    Current Hypertension Reports, Vol. 16, Núm. 2

  4. Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction

    Journal of Human Hypertension, Vol. 28, Núm. 10, pp. 567-574